Related content

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women

By Kanis J.   Borgstrom F.   Johnell O.   Jonsson B.  

Osteoporosis International, Vol. 15, Iss. 11, 2004-11 ,pp. : 862-871

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of alternative treatments for women with osteoporosis in Canada

By Goeree Ron   Blackhouse Gord   Adachi Jonathan  

Current Medical Research and Opinion, Vol. 22, Iss. 7, 2006-07 ,pp. : 1425-1436

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

By Jönsson B.   Ström O.   Eisman J.   Papaioannou A.   Siris E.   Tosteson A.   Kanis J.  

Osteoporosis International, Vol. 22, Iss. 3, 2011-03 ,pp. : 967-982

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of the treatment and prevention of osteoporosis—a review of the literature and a reference model

By Zethraeus N.   Borgström F.   Ström O.   Kanis J.   Jönsson B.  

Osteoporosis International, Vol. 18, Iss. 1, 2007-01 ,pp. : 9-23

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of licensed treatment options for restless legs syndrome in the UK and Sweden

By Lees M.   Roberts G.   Tabberer M.   DasGupta R.   Finnern H. W.    

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2919-2930

Informa Healthcare

Access to resources Recommend Favorite